APA (7th ed.) Citation

Goi, N., Iwata, F., Sugihara, Y., Higa, S., & Chikama, T. (2024). An Open-Label, Phase III Study to Assess the Efficacy and Safety of Cysteamine Ophthalmic Solution 0.55% in Japanese Cystinosis Patients. Clinical Ophthalmology, 18, 3457. https://doi.org/10.2147/OPTH.S479770

Chicago Style (17th ed.) Citation

Goi, Nobuhiro, Fumino Iwata, Yoko Sugihara, Shingo Higa, and Taiichiro Chikama. "An Open-Label, Phase III Study to Assess the Efficacy and Safety of Cysteamine Ophthalmic Solution 0.55% in Japanese Cystinosis Patients." Clinical Ophthalmology 18 (2024): 3457. https://doi.org/10.2147/OPTH.S479770.

MLA (9th ed.) Citation

Goi, Nobuhiro, et al. "An Open-Label, Phase III Study to Assess the Efficacy and Safety of Cysteamine Ophthalmic Solution 0.55% in Japanese Cystinosis Patients." Clinical Ophthalmology, vol. 18, 2024, p. 3457, https://doi.org/10.2147/OPTH.S479770.